Simon Quick Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-773
Closed -$336K 441
2025
Q1
$336K Buy
+773
New +$310K 0.02% 408
2024
Q4
Sell
-688
Closed -$358K 496
2024
Q3
$358K Sell
688
-59
-8% -$31.5K 0.02% 281
2024
Q2
$405K Buy
+747
New +$395K 0.03% 246
2022
Q2
Sell
-294
Closed -$144K 246
2022
Q1
$144K Buy
294
+196
+200% +$89.6K 0.04% 120
2021
Q4
$46K Sell
98
-1,121
-92% -$472K 0.01% 239
2021
Q3
$454K Buy
1,219
+1,121
+1,144% +$426K 0.12% 82
2021
Q2
$37K Buy
98
+50
+104% +$19.1K 0.01% 287
2021
Q1
$17K Buy
+48
New +$15.4K 0.01% 363
2020
Q3
Sell
-9
Closed -$2K 458
2020
Q2
$2K Sell
9
-10
-53% -$2.67K ﹤0.01% 406
2020
Q1
$4K Sell
19
-41
-68% -$11.2K ﹤0.01% 357
2019
Q4
$18K Buy
60
+38
+173% +$10.5K 0.01% 333
2019
Q3
$5K Buy
22
+20
+1,000% +$5.48K ﹤0.01% 302
2019
Q2
$564 Buy
+2
New +$546 ﹤0.01% 451

Other funds holding ELV

Simon Quick Advisors's ELV Position: Q2 2025 in Review

Simon Quick Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 773 shares — an estimated $336K sold.

Simon Quick Advisors first reported a position in ELV in Q2 2019 and held it in 13 quarters. The position peaked at $454K in Q3 2021. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Simon Quick Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 773 Elevance Health shares in Q2 2025, an estimated $336K.
  • Simon Quick Advisors first reported a position in Elevance Health in Q2 2019 and held it in 13 quarters.
  • Simon Quick Advisors's Elevance Health position peaked at $454K in Q3 2021.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Simon Quick Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.